Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis
Albanus O. Moguche, Munyaradzi Musvosvi, Adam Penn‐Nicholson, et al.
Cell Host & Microbe (2017) Vol. 21, Iss. 6, pp. 695-706.e5
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection
Paul K. Drain, Kristina L. Bajema, David W. Dowdy, et al.
Clinical Microbiology Reviews (2018) Vol. 31, Iss. 4
Open Access | Times Cited: 473
The Formation and Function of Granulomas
Antonio J. Pagán, Lalita Ramakrishnan
Annual Review of Immunology (2018) Vol. 36, Iss. 1, pp. 639-665
Open Access | Times Cited: 314
Immune evasion and provocation by Mycobacterium tuberculosis
Pallavi Chandra, Steven J. Grigsby, Jennifer A. Philips
Nature Reviews Microbiology (2022) Vol. 20, Iss. 12, pp. 750-766
Open Access | Times Cited: 312
Immunology ofMycobacterium tuberculosisInfections
Jonathan Kevin Sia, Jyothi Rengarajan
Microbiology Spectrum (2019) Vol. 7, Iss. 4
Open Access | Times Cited: 238
CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection
Yu‐Jung Lu, Palmira Barreira‐Silva, Shayla Boyce, et al.
Cell Reports (2021) Vol. 36, Iss. 11, pp. 109696-109696
Open Access | Times Cited: 123
Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination
David Lewinsohn, David Lewinsohn, Thomas J. Scriba
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 162
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial
Rhea N. Coler, Tracey A. Day, Ruth D. Ellis, et al.
npj Vaccines (2018) Vol. 3, Iss. 1
Open Access | Times Cited: 147
Moving tuberculosis vaccines from theory to practice
Peter Andersen, Thomas J. Scriba
Nature reviews. Immunology (2019) Vol. 19, Iss. 9, pp. 550-562
Open Access | Times Cited: 136
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial
Adam Penn‐Nicholson, Michèle Tameris, Erica Smit, et al.
The Lancet Respiratory Medicine (2018) Vol. 6, Iss. 4, pp. 287-298
Closed Access | Times Cited: 134
Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design
J. Ernst
Cell Host & Microbe (2018) Vol. 24, Iss. 1, pp. 34-42
Open Access | Times Cited: 114
Tuberculosis Vaccine Development: Progress in Clinical Evaluation
Suraj B. Sable, James E. Posey, Thomas J. Scriba
Clinical Microbiology Reviews (2019) Vol. 33, Iss. 1
Open Access | Times Cited: 94
Tuberculosis vaccines: Opportunities and challenges
Bingdong Zhu, Hazel M. Dockrell, Tom H. M. Ottenhoff, et al.
Respirology (2018) Vol. 23, Iss. 4, pp. 359-368
Open Access | Times Cited: 91
Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial
Sara Suliman, Angelique Kany Kany Luabeya, Hennie Geldenhuys, et al.
American Journal of Respiratory and Critical Care Medicine (2018) Vol. 199, Iss. 2, pp. 220-231
Closed Access | Times Cited: 88
Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages
Jason D. Yang, Daniel Mott, Rujapak Sutiwisesak, et al.
PLoS Pathogens (2018) Vol. 14, Iss. 5, pp. e1007060-e1007060
Open Access | Times Cited: 87
New insights into the mycobacterial PE and PPE proteins provide a framework for future research
Louis S. Ates
Molecular Microbiology (2019) Vol. 113, Iss. 1, pp. 4-21
Open Access | Times Cited: 87
Can we predict tuberculosis cure? What tools are available?
Delia Goletti, Cecilia S. Lindestam Arlehamn, Thomas J. Scriba, et al.
European Respiratory Journal (2018) Vol. 52, Iss. 5, pp. 1801089-1801089
Open Access | Times Cited: 86
A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates
Miguel Rodo, Virginie Rozot, Elisa Nemes, et al.
PLoS Pathogens (2019) Vol. 15, Iss. 3, pp. e1007643-e1007643
Open Access | Times Cited: 79
T Cell Immunity to Bacterial Pathogens: Mechanisms of Immune Control and Bacterial Evasion
Freya R Shepherd, James E. McLaren
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6144-6144
Open Access | Times Cited: 73
MAIT cell-directed therapy of Mycobacterium tuberculosis infection
Shunsuke Sakai, Keith D. Kauffman, Sangmi Oh, et al.
Mucosal Immunology (2020) Vol. 14, Iss. 1, pp. 199-208
Open Access | Times Cited: 72
TGFβ restricts expansion, survival, and function of T cells within the tuberculous granuloma
Benjamin H. Gern, Kristin N. Adams, Courtney R. Plumlee, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 594-606.e6
Open Access | Times Cited: 64
A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin
Joshua S. Woodworth, Helena Strand Clemmensen, Hannah Battey, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 61
The Tuberculous Granuloma and Preexisting Immunity
Sara Cohen, Benjamin H. Gern, Kevin B. Urdahl
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 589-614
Open Access | Times Cited: 61
Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection
Sudhasini Panda, Jeffrey Morgan, Catherine Cheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Specific CD4+ T cell phenotypes associate with bacterial control in people who ‘resist’ infection with Mycobacterium tuberculosis
Meng Sun, Jolie M. Phan, Nathan S. Kieswetter, et al.
Nature Immunology (2024) Vol. 25, Iss. 8, pp. 1411-1421
Open Access | Times Cited: 12
MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic
Jesús Gonzalo‐Asensio, Dessislava Marinova, Carlos Martı́n, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 84
Page 1 - Next Page

Scroll to top